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Increased activity of the sympathetic nervous system has been highlighted as a key factor that con-
tributes to the development and maintenance of arterial hypertension. However, the factors that pre-
cipitate sustained increases in sympathetic activity remain poorly understood. Resting tissue oxygen
partial pressure (PtO2) in the brainstem of anesthetized spontaneously hypertensive rats (SHRs) has been
shown to be lower than in normotensive rats despite normal levels of arterial PO2. A hypoxic environ-
ment in the brainstem has been postulated to activate astroglial signalling mechanisms in the rostral
ventrolateral medulla (RVLM) which in turn increase the excitability of presympathetic neuronal net-
works. In this study, we assessed the expression of indirect markers of tissue hypoxia and astroglial cell
activation in the RVLM of SHRs and age-matched normotensive Wistar rats. Immunohistochemical la-
belling for hypoxia-induced factor-1α (HIF-1α) and bound pimonidazole adducts revealed the presence
of tissue hypoxia in the RVLM of SHRs. Double immunostaining showed co-localization of bound pi-
monidazole labelling in putative presympathetic C1 neurons and in astroglial cells. Quantiﬁcation of glial
ﬁbrillary acidic protein (GFAP) immunoﬂuorescence showed relatively higher number of astrocytes and
increased GFAP mean grey value density, whilst semi-quantitative analysis of skeletonized GFAP-im-
munoreactive processes revealed greater % area covered by astrocytic processes in the RVLM of adult
SHRs. In conclusion, the morphological ﬁndings of tissue hypoxia and astrogliosis within brainstem
presympathetic neuronal networks in the SHR support previous observations, showing that low brain-
stem PtO2 and increased astroglial signalling in the RVLM play an important role in pathological sym-
pathoexcitation associated with the development of arterial hypertension.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
There is mounting evidence that increased sympathetic ner-
vous system (SNS) activation is intricately linked to the develop-
ment and maintenance of arterial hypertension, although the
causative role is still controversial. Human studies have shown
elevated plasma noradrenaline and increased vasoconstrictor
sympathetic activity in individual organs such as the kidneys,
heart and skeletal muscle in hypertensive patients (Esler et al.,r B.V. This is an open access articl
F-1α, hypoxia-induced factor
al pressure; RVLM, rostral
sive rats; SNS, sympathetic
ical Pharmacology, University1989, 2001, 1988) and it is estimated that over 50% of cases of
essential hypertension are characterized by a substantial neuro-
genic component (Esler, 2010).
The mechanisms leading to increased SNS activity remain
poorly understood, but recent studies have suggested that local
abnormalities in oxygen homeostasis in the brainstem areas that
generate sympathetic tone might play a substantial role. The
brainstem vasculature in hypertensive patients and in the spon-
taneously hypertensive rat model (SHR) has been shown to be
considerably narrow with a high resistance to blood ﬂow and thus
presympathetic networks that control blood pressure have been
proposed to be hypoperfused (Cates et al., 2011; 2012a). There is
also evidence that neurovascular coupling responses triggered by
neuronal stimulation are signiﬁcantly impaired in the brain of
hypertensive subjects (Jennings et al., 2005; Calcinaghi et al., 2013;
Iddings et al., 2001). Together, these abnormalities may cause
important reductions in cerebral blood ﬂow in hypertensivee under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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trolateral medulla (RVLM) of anesthetized animals (via oxygen-
sensitive ﬁber optic probe) have recently shown that local PtO2
levels in spontaneously hypertensive rats (SHRs) are signiﬁcantly
lower compared to control Wistar rats despite normal levels of
arterial PO2 (Marina et al., 2015). This suggests that at resting
conditions, the brainstem of hypertensive animals operates in
hypoxic conditions.
Hypoxia is a well-known sympathoexcitatory stimulus leading
to increased peripheral vascular resistance and increased arterial
blood pressure (Sun and Reis, 1994). However, recent evidence
indicates that sympathoexcitatory responses to hypoxia are in-
directly mediated by prior activation of astroglial signalling me-
chanisms driven by the release of ATP and L-lactate (Marina et al.,
2015). These (glio-) transmitters have been shown to increase
neuronal excitability of pre-sympathetic C1 neurons of the RVLM,
leading to increased sympathetic outﬂow and concomitant hy-
pertension (Marina et al., 2015, 2016). However, the hypothesis
that brainstem hypoxia and glial cell activation play a central role
in sympathoexcitatory mechanisms associated with the develop-
ment of hypertension still lacks important morphological clues.
Thus, the purpose of this study was to compare the presence of
tissue hypoxia and glial cell activation in the RVLM of SHRs and
normotensive healthy controls.2. Results
2.1. Detection of tissue hypoxia in the RVLM
We used two independent immunohistochemical methods to
investigate the presence of tissue hypoxia in the brainstem of
hypertensive rats. First, abundant hypoxic cells were identiﬁed in
the C1 region of naïve SHRs and to a much lesser extent in Wistar
rats immunolabelled for HIF-1α. The labelling was mainly located
within the cytoplasm of unidentiﬁed cellular structures within the
RVLM. We found greater numbers of HIF-1α-immunoreactive (-ir)
cells in the C1 region of SHRs compared to Wistar rats
(276.4749.8 cells in SHRs vs 53.1723.3 cells in Wistar rats,
po0.001, n¼5; Fig. 1). Second, in animals that received a systemic
administration of pimonidazole, we detected clear labelling for
bound pimonidazole in the brainstem of hypertensive rats and
also, to a much lesser extent in control Wistar rats. The presence of
bound pimonidazole adducts revealed by either im-
munoperoxidase or immunoﬂuorescence methods was character-
ized by diffuse labelling in the RVLM parenchyma. Optical densi-
tometric analysis of bound pimonidazole revealed increased im-
munoperoxidase labelling in the RVLM of SHRs compared to
Wistar rats (113.5711.3 a.u. in SHRs vs 76715.6 a.u. in Wistar
rats, p¼0.02; Fig. 2A–D). Similar differences were observed in
tissue labelled with immunoﬂuorescence methods (6.570.6 a.u.
in SHRs vs 3.170.5 a.u. in Wistar rats, p¼0.004; Fig. 2E–H).Fig. 1. HIF-1α labelling in the brainstem of SHRs and Wistar rats. (A) Schematic repres
IOPr¼Principal nucleus of the Inferior Olive; Sp5¼Spinal trigeminal tract. Representative
higher average number of cells expressing HIF-1α in the C1 region of adult SHRs compar
test was used for statistical comparison. (*Signiﬁcant difference compared with WistarDouble immunoﬂuorescence labelling for pimonidazole and cell-
speciﬁc markers for C1 catecholaminergic neurons and astroglial
cells in the brainstem of SHRs revealed co-localization in the
majority of tyrosine hydroxylase- (TH-) positive neurons and
GFAP-positive astroglial cells residing within the C1 area (Fig. 3).
2.2. Glial cell activation in the RVLM of SHRs
As increased astroglial signalling in the brainstem has been
shown to play a signiﬁcant role in sympathoexcitatory mechan-
isms associated with the development of arterial hypertension, we
sought to detect anatomical evidence of glial cell activation in the
RVLM of SHR (Fig. 4). Quantiﬁcation of GFAP-immunoﬂuorescence
in the C1 region revealed increased number of GFAP-ir astrocytes
in SHRs compared to Wistar rats (76.572.7 cells in SHRs vs
27.978.1 cells in Wistar rats, p¼0.004; Fig. 4C) as well as in-
creased mean grey value of GFAP staining (MGV, 4.170.9 a.u. in
SHRs vs 1.470.1 a.u. in Wistar rats, p¼0.02; Fig. 4D). Semi-
quantitative analysis of GFAP-ir skeletonized processes showed
greater % area occupied by astrocytic processes in the C1 region of
SHRs (7.572.1% in SHRs vs 2.870.3% in Wistar rats, p¼0.001;
Fig. 4E).3. Discussion
In this study we sought to obtain immunohistochemical evi-
dence that in the SHR, brainstem presympathetic networks that
control arterial blood pressure are embedded in a hypoxic mi-
croenvironment. First, using two independent immunolabelling
methods, we conﬁrmed the presence of tissue hypoxia in the
RVLM of the SHR. Next, we found which cells in the RVLM show
this hypoxic phenotype. Finally, we determined the presence of
astrogliosis in the RVLM of SHRs using three independent methods
for semi-quantitative assessment of GFAP immunolabelling.
3.1. Tissue hypoxia
The brain is highly vulnerable to the harmful effects of sus-
tained arterial hypertension because it is dependent on luxuriant
blood ﬂow for its energy requirements. Hypertension accelerates
atheroschlerotic plaque formation in the cerebrovascular tree
which may lead to microvascular brain damage, stenosis and
stroke. In the brainstem, hypertension has been shown to induce
considerable remodelling of the basilar artery and increased vas-
cular resistance and together, these factors are believed to com-
promise brainstem perfusion (Cates et al., 2012b, 2011, 2012a;
Dickinson and Thomson, 1960). In a recent study, we showed that
PtO2 measurements in the C1 region of isoﬂurane-anesthetized
SHRs are signiﬁcantly lower compared to normotensive Wistar
rats, despite normal levels of arterial PO2 (Marina et al., 2015).
Paradoxically, RVLM hypoxia was exacerbated when arterial bloodentation of brainstem transverse section indicating the location of the C1 region.
micrographs from a normotensive Wistar (B) and SHR (C). (D) Group data showing
ed to age-matched Wistar controls. Data are presented as mean7SEM. Unpaired t-
rats P¼0.001).
Fig. 2. Pimonidazole labelling in the C1 area of SHR and Wistar rats. Representative micrographs of coronal brainstem sections labelled with immunoperoxidase (A–C) or
immunoﬂuorescence methods (E–G). Absence of labelling in negative controls is shown in (A) and (E). Micrographs corresponding to Wistar rats are shown in (B) and (F).
Micrographs corresponding to SHRs are shown in (C) and (G). Group data showing increased pimonidazole immunoperoxidase labelling (D) and immunoﬂuorescence
labelling (H) in the C1 region of SHRs compared to age-matched Wistar controls. Data are presented as mean7SEM. Unpaired t-tests were used for statistical comparison.
[*Signiﬁcant difference compared with Wistar rats P¼0.02 (D) and P¼0.004 (H)].
Fig. 3. Pimonidazole labelling in speciﬁc cell types of the RVLM. (A1) and (B1), Representative micrographs of coronal brainstem sections showing pimonidazole im-
munoﬂuorescent labelling in the C1 region of SHRs. Double immunostaining for tyrosine hydroxylase (TH; A2) and glial ﬁbrillary acidic protein (GFAP; B2). Colour merge
revealed co-localization of pimonidazole immunolabelling with the majority of TH-ir C1 neurons (A3, thick arrows) and with GFAP-ir astrocytes (B3, thin arrows).
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normotensive animals (Marina et al., 2015). Central hypoxia is a
powerful sympathoexcitatory stimulus (Sun and Reis, 1994) and in
subjects with arterial hypertension, this mechanism is believed to
induce compensatory increases in sympathetic outﬂow and sys-
temic blood pressure in order to overcome excessive resistance at
the level of the basilar artery with the aim of preventing the ex-
acerbation of brainstem hypoxia (Cushing mechanism) (Cates
et al., 2012a, 2011, 2012b; Marina et al., 2015).
In our study, immunolabelling of tissue hypoxia markers in the
C1 region was consistently higher in SHRs. Our results show that
HIF-1α immunostaining was localized in cells that judged by their
size and morphology, resemble neuronal structures. However, due
to technical reasons we were unable to demonstrate the identity of
these cells. On the other hand, bound pimonidazoleimmunoﬂuorescence in the RVLM of SHRs was found in cell types
identiﬁed as catecholaminergic neurons and in astroglial cells
suggesting that both cell groups are indeed hypoxic. In the RVLM,
pre-sympathetic neurons were believed to be directly sensitive to
hypoxia (Dampney and Moon, 1980; Sun and Reis, 1994). However,
recent evidence has shown that presympathetic neurons do not
respond directly to hypoxia, but sense ATP and lactate released by
neighbouring astrocytes (Marina et al., 2015). Brainstem astrocytes
are physiological oxygen sensors in the brain, responding to de-
creases in PO2 a few mmHg below normal brain oxygenation with
elevations in intracellular [Ca2þ], leading to ATP and lactate re-
lease which in turn activate presympathetic neurons resulting in
increased renal sympathetic activity and arterial blood pressure
(Marina et al., 2015; Angelova et al., 2015; Karagiannis et al., 2016).
We have shown that accumulation of ATP in the RVLM contributes
Fig. 4. Immunolabelling of astrocytes in the RVLM rats. Representative micrographs of coronal brainstem sections labelled immunohistochemically to detect glial ﬁbrillary
acidic protein (GFAP) in the C1 region of SHRs (A1) and Wistar rats (A2). Skeletonized images used for the analysis are shown in B1 and B2, respectively. Group data showing
increased number of GFAP-ir astrocytes (C), increased mean grey value (MGV) (D) and larger % area covered by GFAP-ir astroglial processes (E) in the in the C1 region of SHRs
in comparison to Wistar rats. Data presented as mean7SEM. Unpaired t-test was used for statistical comparisons. [*Signiﬁcant difference compared with Wistar rats
P¼0.004 (C), P¼0.02 (D) and P¼0.01 (E)].
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systemic hypertension (Marina et al., 2015). To interfere with ATP-
mediated signalling, we used a lentiviral vector to express a potent
ectonucleotidase—transmembrane prostatic acid phosphatase
(TMPAP). TMPAP promotes breakdown of extracellular ATP and
expression of TMPAP within RVLM pre-sympathetic circuits re-
duces sympathoexcitation and the development of arterial hy-
pertension in the SHRs (Marina et al., 2013, 2015). Thus, we believe
that a local hypoxic environment in the RVLM triggers astroglial
cell activation leading to SNS activation and compensatory hy-
pertension (Cushing mechanism), the purpose of which is to
preserve brain perfusion. However, this mechanism has the po-
tential to become maladaptive resulting in systemic hypertension
(the so-called “selﬁsh brain” hypothesis) (Rodbard and Stone, 1955;
Dickinson and Thomson, 1960; Paton et al., 2009; Cates et al.,
2011; Marina et al., 2015).3.2. Astrogliosis in the RVLM
Our results show the presence of glial cell activation in the C1
region of SHRs, characterized by increased number of GFAP-ir as-
trocytes, increased GFAP mean grey value intensity and increased
% C1 area occupied by GFAP-ir astrocytic processes. Astrocytes
residing in the RVLM have been shown to have a profound inﬂu-
ence on the activity of bulbospinal sympathoexcitatory neurons.
Optogenetic activation of RVLM astrocytes in vitro (transduced to
express channelrhodopsin2) increases the excitability of catecho-
laminergic presympathetic neurons which belong to the C1 group
(Marina et al., 2013). These responses were found to be sig-
niﬁcantly attenuated in the presence of ATP-degrading enzyme
apyrase, indicating a pivotal role for ATP in astrocyte-mediated
activation of presympathetic neurons (Marina et al., 2013). Fur-
thermore, optogenetic activation of ChR2-expressing astrocytes
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creases in renal sympathetic nerve activity, heart rate and arterial
blood pressure (Marina et al., 2013). Increased expression of GFAP
is indicative of reactive astrogliosis – as deﬁned by glial cell acti-
vation due to injury or pathological processes including hypoxia,
infection and trauma (Eng and Ghirnikar, 1994). Thus, our im-
munohistochemical ﬁndings provide morphological evidence of
astrogliosis in the RVLM of SHRs which is consistent with our
previous observations showing increased astroglial signalling in
the RVLM of SHRs (Marina et al., 2015). However, the mechanisms
leading to astrogliosis in the brainstem of hypertensive rats as well
as the biological effects of reactive astrocytes surrounding pre-
sympathetic networks that control arterial blood pressure are
unknown. It remains to be determined whether gliotransmitter
release mechanisms are exaggerated in reactive astrocytes.
In summary, the data obtained in the present study supports
our hypothesis that tissue hypoxia in the RVLM is a key element of
the Cushing mechanism and the morphological ﬁnding of astro-
gliosis in the C1 region of the SHR provides an anatomical sub-
strate that links cerebrovascular abnormalities and brainstem hy-
poperfusion with increased SNS activity. Thus, we propose that
sustained activation of RVLM astrocytes (either in response to lo-
calized hypoxia, inﬂammation, reactive oxygen species, etc.) fa-
cilitates the stimulation of presympathetic C1 neurons, leading to
maladaptive increases in SNS activity and elevated arterial blood
pressure (Marina et al., 2016). Future studies should evaluate
whether sex has an impact on these pathophysiological
mechanisms.4. Experimental procedure
All animal experimentations were performed in accordance
with the European Commission Directive 86/609/EEC (European
Convention for the Protection of Vertebrate Animals used for Ex-
perimental and Other Scientiﬁc Purposes) and the United Kingdom
Home Ofﬁce (Scientiﬁc Procedures) Act (1986) and ARRIVE (Ani-
mal Research: Reporting of In Vivo Experiments) guidelines with
project approval from the UCL Institutional Animal Care and Use
Committee.
4.1. Histological assessment of tissue hypoxia and glial cell activation
Brainstem tissue from naïve adult (15 weeks) male SHRs (n¼5)
and age- and sex-matched normotensive Wistar rats (n¼5) was
used for immunohistochemical detection of HIF1α (indirect mar-
ker of tissue hypoxia) and GFAP (astroglial marker). In a separate
group of rats, tissue hypoxia was assessed by immunodetection of
bound pimonidazole HCl protein-thiol adducts (Davies et al.,
2013). Brieﬂy, adult (15 weeks) male SHRs (n¼5) and age- and
sex-matched Wistar rats (n¼4) were injected with pimonidazole
(60 mg/kg i.p. dissolved in sterile saline, Hypoxyprobe, HPI Inc.,
USA) 4 h before terminal anaesthesia for intracardiac ﬁxation. In
conditions of hypoxia, pimonidazole is enzymatically reduced and
it binds to tissue where it can be visualized using im-
munohistochemistry and it has been previously shown to be a
reliable marker of hypoxia in the central nervous system (Davies
et al., 2013; Arteel et al., 1998).
Animals were deeply anesthetized with urethane (1.9 g kg1 i.
p) and transcardially perfused with ice-cold 0.9% sodium chloride
solution followed by 4% paraformaldehyde at 4 °C. Brains were
extracted, postﬁxed in PFA overnight, and cryoprotected in 30%
sucrose for 48 h at 4 °C. Brainstems were sectioned with a cryostat
(Bright instruments, UK) along the rostro-caudal extent of the
RVLM (starting caudally from the area postrema (AP) and ﬁnishing
approximately 2 mm rostral to the AP). Transverse sections(30 mm) were collected serially in 6 well plates containing anti-
freeze solution (Marina et al., 2002) and stored at 21 °C until
further processing.
4.2. Immunohistochemistry
HIF1-α, pimonidazole, GFAP, and TH were detected by im-
munoﬂuorescence methods. Negative controls were performed for
each antibody by omitting the primary antibody. Free-ﬂoating
sections were washed 3 times for 5 min in 0.1 M phosphate-buf-
fered saline (PBS) and where necessary, were incubated in special
buffers for antigen retrieval [DAKOs Target retrieval solution (pH
6.0) for HIF1-α and sodium borohydride (1 mg/ml in PBS) for Pi-
monidazole]. Brainstem sections were then incubated in blocking
buffer for 1 h, to minimise non-speciﬁc binding of the antibody
and for cell membrane permeabilisation (10% goat serum in 0.1%
Triton in PBS for HIF1-α and 0.25% casein in 0.1% Triton in PBS for
Pimonidazole, TH and GFAP). Tissue was incubated in primary
antibodies diluted in blocking buffer for 48 h at 4 °C [Rabbit anti-
HIF1-α (1:500, Novus-Bio); Mouse anti-Pimonidazole (1:200, HPI
Inc); Rabbit anti-Tyrosine Hydroxylase (1:500, Abcam); Rabbit
anti-glial ﬁbrillary acidic protein GFAP (1:500, Dako)]. Tissue was
washed 3 times with PBS and subsequently incubated in second-
ary antibodies for 2 h [Alexa Fluor 488 Donkey anti-rabbit or Alexa
Fluor 568 Donkey anti-mouse (1:1000, Molecular probes)]. For
double immunostaining protocols, two separate sets of serial his-
tological sections were ﬁrst stained for pimonidazole, followed by
either TH or GFAP. After 3 ﬁnal washes in PBS, the tissue was
mounted on glass slides and cover-slipped with Fluoroshields
(Sigma).
Pimonidazole binding was also detected in a separate set of
serial sections by the immunoperoxidase method. Endogenous
peroxidase activity was eliminated with 0.3% H2O2 diluted in
methanol. The sections were washed in PBS and incubated in
primary antibody followed by biotinylated horse anti-mouse sec-
ondary antibody (1:200, Vector Laboratories). The Avidin-Biotin
complex (ABC) protocol was followed using Vectastains Elite ABC
kit (Vector Laboratories) with 3-3′ Diaminobenzidine as the
chromogen. The tissue was mounted on glass slides and air-dried
overnight, followed by dehydration in ethanol (70%, 90%, 100%)
and xylene (twice each and for 2 min per step) and cover-slipped
with DPX (Thermo Scientiﬁc™).
4.3. Image analysis
Digital images were captured using a Leica DM2000 ﬂuores-
cence microscope (Leica Microsystems, Germany) coupled to a
Retiga 3000C camera (Q Imaging, Canada). The C1 region was
deﬁned as the area located near the ventral medullary surface
between the principal nucleus of the inferior olive (IO Pr) and the
spinal trigeminal tract (Sp5). Two images were captured per slice
with either 10 or 20 objectives (one from each ipsilateral C1
region) with a total of 5 sections covering the rostro-caudal extent
of the C1 area (approximately between 11.60 mm and 12.80 mm
caudal to Bregma). All images were captured by a blind in-
vestigator during the same session and using the same camera
settings. Images were analysed using WCIF ImageJ software as
follows:
4.4. HIF1-α cell counts
Micrographs were captured at 10X and converted to 16-bit
scale. The cell counter plugin was used to quantify the total
number of labelled cells in the C1 region regardless of their size or
label intensity.
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Micrographs were captured using a 10 objective. Images with
white DAB signal on a black background were obtained after the
original image was inverted and converted into 8-bit scale. Mean
grey value (MGV) was determined using the analysis function in
imageJ and the value was corrected by subtracting the level of
background staining from an image of a slice incubated in the
absence of primary antibody. Data are expressed as average pi-
monidazole labelling in arbitrary units (a.u.).
4.6. Pimonidazole immunoﬂuorescence intensity
Images were captured at 10 magniﬁcation and converted to
8-bit scale. MGV was calculated as a measure of immuno-
ﬂuorescence intensity of pimonidazole. Data are shown as average
intensity of immunoﬂuorescence expressed in a.u.
4.7. GFAP analysis
Micrographs were captured at 20 and converted into 16 bit
scale. The cell counter plugin was used to quantify manually the
total number of labelled cells per image. Only cell bodies clearly
identiﬁed by GFAP-immunoﬂuorescence regardless of their label
intensity, size and number and length of astroglial processes were
included in the analysis. Grey scale images were then transformed
into binary images using the threshold function and were subse-
quently skeletonized using Skeletonize 2D/3D plugin. MGV and %
area occupied by GFAP-ir skeletonized processes were quantiﬁed
using the analysis function.
4.8. Data analysis
Immunohistochemical levels of expression of tissue hypoxia
and glial cell activation markers are presented as mean7SEM and
were compared using unpaired, two-sample, two-tailed Student's
t-test. The difference was deemed statistically signiﬁcant at the
level of po0.05.Funding sources
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